THC-A: The Little Known Cannabinoid with Big Potential

When it comes to cannabinoids, most people are familiar with THC and CBD. However, there is another cannabinoid that is gaining attention for its potential health benefits: THC-A. THC-A, or tetrahydrocannabinolic acid, is the precursor to THC and is found in raw cannabis. In this blog post, we’ll take a closer look at THC-A and its potential benefits.

What is THC-A?

THC-A is a non-psychoactive cannabinoid that is found in raw cannabis. When cannabis is heated or decarboxylated, THC-A is converted into THC, the cannabinoid responsible for the plant’s psychoactive effects. THC-A is not intoxicating on its own, but it does have potential therapeutic effects.

Potential Benefits of THC-A

While research on THC-A is still in its early stages, there are some potential benefits that have been identified. Here are a few:

  • Anti-inflammatory: THC-A has been shown to have anti-inflammatory properties, which could make it a potential treatment for conditions such as arthritis and multiple sclerosis.
  • Neuroprotective: Studies have shown that THC-A may have neuroprotective effects, making it a potential treatment for conditions such as Alzheimer’s and Parkinson’s disease.
  • Anti-nausea: THC-A has been shown to have anti-nausea properties, which could make it a potential treatment for nausea and vomiting associated with chemotherapy and other medical treatments.
  • Appetite stimulation: THC-A has been shown to stimulate appetite, which could be beneficial for people with eating disorders or those undergoing medical treatments that suppress appetite.





  1. Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364.
  2. Rock, E. M., Kopstick, R. L., Limebeer, C. L., & Parker, L. A. (2013). Tetrahydrocannabinolic acid reduces nausea‐induced conditioned gaping in rats and vomiting in Suncus murinus. British Journal of Pharmacology, 170(3), 641-648.
  3. Takeda, S., Okajima, S., Miyoshi, H., Yoshida, K., Okamoto, Y., Okada, T., & Amamoto, T. (2008). Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug metabolism and disposition, 36(9), 1917-1921.

Put your feet up and let us do the hard work for you. Sign up to receive our latest deals directly in your inbox.

We’ll never send you spam or share your email address.

Leave a Reply

Your email address will not be published. Required fields are marked *

Are you 21 or older? This website sells products that require you to be 21 years of age or older to purchase. Please verify your age to view the content, or click "Exit" to leave.